People · Operator

James Dreyfous

Named in public records as an officer, director or promoter · active 2009–2013 · Other

2
Companies
7
Filings
$48.7M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Adapx IncOtherSeries A$36.7M$28.3M2009
Venafi, IncOtherSeries A$12.0M$181.6M2012
Operator network

James Dreyfous at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Chad Waite · 11 companies · 1 sharedChad WaiteCharles Waite · 2 companies · 1 sharedCharles WaiteKenneth Schneider · 2 companies · 1 sharedKenneth SchneiderChris P. Weber · 1 companies · 1 sharedChris P. WeberChris Weber · 1 companies · 1 sharedChris WeberDavid McGee · 1 companies · 1 sharedDavid McGeeMark Maloney · 1 companies · 1 sharedMark MaloneyMark Shapland · 1 companies · 1 sharedMark ShaplandPeter W. Chiarelli · 1 companies · 1 sharedPeter W. ChiarelliPhilip Cohen · 1 companies · 1 sharedPhilip CohenPhillip Cohen · 1 companies · 1 sharedPhillip CohenGreg Butterfield · 7 companies · 1 sharedGreg ButterfieldSkip Glass · 3 companies · 1 sharedSkip GlassJeff Hudson · 2 companies · 1 sharedJeff HudsonBill Elmore · 1 companies · 1 sharedBill ElmoreAdapx Inc · $36.7M raisedAdapx IncVenafi, Inc · $12.0M raisedVenafi, IncJames DreyfousJD
James Dreyfous Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside James Dreyfous on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Chad Waite111
Greg Butterfield17
Skip Glass13
Kenneth Schneider12
Jeff Hudson12
Charles Waite12
Phillip Cohen11
Chris P. Weber11
Peter W. Chiarelli11
Bill Elmore11
Philip Cohen11
Chris Weber11
David McGee11
Mark Shapland11
Mark Maloney11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.